English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMount Sinai researchers, in collaboration with scientists at The Rockefeller University, have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems.
Tag: Mount Sinai Health System
Mount Sinai Study Calls for Major Changes in the Way People With Comorbidities Are Selected by Physicians for Lung Cancer Screening
A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients on whether to proceed with lung cancer screening is fraught with confusion and lack of evidence-based information, and may actually be undermining the purpose for which it was created, Mount Sinai researchers say.
Mount Sinai Is First in New York to Study a Brain-Computer Interface Designed to Record and Map the Brain’s Activity in Unprecedented Detail
A multidisciplinary team of neurosurgeons and neuroscientists from the Icahn School of Medicine at Mount Sinai are the first in New York to study a new brain-computer interface that’s engineered to map a large area of the brain’s surface, in real time, at resolutions hundreds of times more detailed than typical arrays used in neurosurgical procedures.
Mount Sinai Experts Available for Interview During Endometriosis Awareness Month
Contact: Stacy A. Anderson Mount Sinai Press Office 347-346-3390 [email protected] (New York, NY – March 21, 2024) – As we continue to recognize March as Endometriosis Awareness Month, observed to bring attention to the…
Mount Sinai Experts to Present New Research at 71th Annual Meeting of the Society for Reproductive Investigation
Researchers available for interview about their new studies and other women’s health topics
Artificial Intelligence Matches or Outperforms Human Specialists in Retina and Glaucoma Management, Mount Sinai Study Finds
Research shows this tool can strongly support clinicians for patient care
Mount Sinai Receives $2.6 Million Grant From PolyBio Research Foundation for Long COVID Clinical Trials
Funding will also support researching other complex illnesses and medical education
Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society
World leader in aortic valve reconstruction is first Mount Sinai surgeon to lead the international organization
A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer
Results of 16-Center REVIVE trial published in The New England Journal of Medicine
Mount Sinai Named Official Medical Service Provider for International Sumo League
Physicians from the Department of Rehabilitation and Human Performance will play a key role in preparing athletes for tournaments
Mount Sinai Doctors to Present New Research at 2024 SMFM Annual Pregnancy Meeting
High-risk pregnancy specialists from the Mount Sinai Health System are presenting research at the Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine (SMFM) from February 10-14
Mount Sinai Ophthalmologists Develop Novel Protocol to Rapidly Diagnose and Treat Eye Stroke
Study shows using advanced technology and time can prevent permanent vision loss
Mount Sinai Researchers Receive $5 Million Gift From the Blavatnik Family Foundation to Expand Revolutionary Organ Perfusion Platform
The Mount Sinai Recanati/Miller Transplantation Institute has received a $5 million gift from the Blavatnik Family Foundation, pledged across five years.
Quality of Care for Patients Who Call 911 Varies Greatly Across the United States, Study Finds
Mount Sinai research could lead to more consistency and safety measure.
Global Taskforce of Scientists Develop a Unifying Framework for the Human Affectome
Work will facilitate interdisciplinary study of feelings, emotions, moods, and other sensory experiences, as well as the development of treatments for mental disorders.
Mount Sinai Researchers Awarded $4.1 Million NIH Grant to Advance Understanding of Sleep Apnea Using Artificial Intelligence
Machine-learning method aims to predict consequences of serious sleep disorder impacting millions in the U.S.
Mount Sinai Study Shows That Circulating Immune Cells Drawn to the Brain During Stress Can Control Emotional Behaviors
Findings shed light on mechanisms underlying psychosocial stress and depression susceptibility
Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation
FOR IMMEDIATE RELEASE Contact: Ilana Nikravesh Mount Sinai Press Office 212-241-9200 [email protected] …
Mount Sinai Leaders Showcase Innovations and Solutions in Health Delivery and Care Quality at Arab Health 2024
Mount Sinai Health System leaders will attend and present at Arab Health 2024, the Middle East’s largest healthcare exhibition and congress, on January 29 – February 1
Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer
Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.
Mount Sinai Selikoff Centers for Occupational Health Receives New Funding Totaling Over $12 Million
New 5-year contracts for the Mid-Hudson Valley and New York City region support continued clinical services, outreach, and education to injured and sick workers.
Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation
The Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, the second most common blood cancer in the United States.
Mount Sinai Health System Receives 2023 CHIME Digital Health Most Wired Recognition
Mount Sinai receives award honoring health organizations that use information technology to enhance health care and outcomes
Women With Atrial Fibrillation Significantly Benefit From Pulsed Field Ablation Procedures
Mount Sinai-led study is the first to show there are no sex disparities in patient outcomes with this new technology
Largest Brain Autopsy Study of Female Intimate Partner Violence Decedents Reveals Brain Injury Pathology Unlike That Seen Among Male Contact Sports Athletes
The largest brain autopsy study of women who had experienced intimate partner violence reveals substantial vascular and white matter damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognized among male contact sports athletes who sustain repeated head trauma.
Mount Sinai Receives $4.6 Million From The Pershing Square Foundation to Support Women’s Health Research and Careers for Women in Science
The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from The Pershing Square Foundation to support women’s health research and advance careers for female scientists
Mount Sinai Renames Top-Ranked Heart Hospital to Honor Valentin Fuster, MD, PhD, and His Legacy of Excellence
“Mount Sinai Fuster Heart Hospital” furthers vision of world-leading cardiac care and research that prevents heart disease worldwide
Certain Per- and Polyfluoroalkyl “Forever Chemicals” Identified as Potential Risk Factor for Thyroid Cancer
Mount Sinai researchers have discovered a link between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk for thyroid cancer.
Adding Immunotherapy to Chemotherapy Regimen Improves Survival in Metastatic Bladder Cancer Patients
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously reported in The New England Journal of Medicine and at the annual meeting of the European Society for Medical Oncology.
Oula Announces Third Clinic And Expanded Partnership With Mount Sinai Health System To Provide Wider Access To Collaborative Maternity Care
Oula-Mount Sinai West partnership offers patients the best of obstetrics and midwifery, with midwife-led delivery supported by leading hospital’s expertise and resources
CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
CastleVax, a clinical stage vaccine platform company, has received a Project NexGen award valued at up to $338 million from the Biomedical Advanced Research and Development Authority (BARDA), to support the development of a next-generation, booster vaccine to protect against COVID-19 for years to come.
NIH Awards Mount Sinai Researchers $12 Million to Personalize Sickle Cell Treatment
The Mount Sinai Health System has received a $12,180,625 grant from the National Heart, Lung and Blood Institute to compare new treatment options for sickle cell disease and determine which work best for specific patients.
Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research
Agreement aims to help make clinical trials more efficient and lead to faster advances in patient care
Advanced Bladder Cancer Patients Could Keep Their Bladder Under New Treatment Regime, Clinical Trial Shows
Mount Sinai investigators have developed a new approach for treating invasive bladder cancer without the need for surgical removal of the bladder, according to a study published in Nature Medicine in September.
Mount Sinai Rehabilitation Centers Ranked Among the Best in the United States by Newsweek
Top rankings include Mount Sinai Morningside and The Mount Sinai Hospital, with stroke rehabilitation a standout program
People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition
Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it
Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression
A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression.
Certain Community Health Care Worker Programs Often Exploit Volunteers, Mount Sinai Researchers Report
First systematic study of the subject finds that more than half of unsalaried community health care workers in dual-cadre programs experienced unfair treatment in the workplace
Preschoolers From Low-Income Families May Have Worse Health and Benefit Less From Health Promotion Interventions Than Children With Higher Socioeconomic Status
Mount Sinai study focused on Harlem preschools emphasizes the need for specialized health promotion programs in classrooms starting at an early age
Icahn School of Medicine at Mount Sinai Licenses Next-Generation Diagnostic Test Epigenetic /AI Platform to GNOMX Corp.
The Icahn School of Medicine at Mount Sinai has agreed to an exclusive license option with GNOMX Corp. (GNOMX) for epigenetic diagnostic and prognostic technology for infectious diseases.
Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV
The National Cancer Institute has awarded the Icahn School of Medicine at Mount Sinai a $3.4 million grant to create a model that identifies the best prostate cancer treatment for people with HIV.
Mount Sinai Researchers Develop Novel, Automated Measure of Sleep Studies to Determine Severity of Obstructive Sleep Apnea
New method can predict risks of cardiovascular disease, mortality in sleep apnea patients
Mount Sinai Announces Partnership With the Brazilian Clinical Research Institute to Advance Cardiovascular Disease Research and Medical Education
Agreement aims to improve patient care and outcomes on a global scale
Optical Coherence Tomography May Improve Safety and Outcomes for Stenting Procedures in Heart Disease Patients Compared to Conventional Angiography
Results from a large-scale clinical trial results could increase usage of high resolution imaging for guiding interventional coronary procedures
Mount Sinai Researchers Find Asian Americans to Have Significantly Higher Exposure to “Toxic Forever” Chemicals
Asian Americans have significantly higher exposure than other ethnic or racial groups to PFAS, a family of thousands of synthetic chemicals also known as “toxic forever” chemicals, Mount Sinai-led researchers report.
Mount Sinai Study Identifies Most Effective and Safest Outpatient Labor Induction Methods, Potentially Reducing Hospital Stays and Increasing Hospital Efficiency in Use of Resources
Mount Sinai study identifies most effective and safest outpatient labor induction methods, potentially reducing hospital stays and increasing hospital efficiency in use of resources
Mount Sinai Honored on Forbes’s “America’s Best-in-State Employers” List
The Mount Sinai Health System was recognized today as an outstanding health care employer in New York, ranking in the top 15 on the prestigious Forbes list of “America’s Best-in-State Employers.”
Mount Sinai Receives Significant Funding to Study Which Coronary Revascularization Procedure Best Improves Survival and Quality of Life for Women and Underserved Minority Groups
The Icahn School of Medicine at Mount Sinai will help lead and launch the first clinical trial focusing on women and minority populations to determine which coronary revascularization procedure best improves their survival and quality of life.
Father’s Psychiatric Diagnosis Increases Risk of Preterm Birth, Study Reports
Babies are more likely to be born prematurely when either their father or mother has had a psychiatric diagnosis, according to a study.
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.